(Q61957476)
Statements
Adjuvant Pegylated-Interferon-alpha2b (SylatronTM) for 2 Years Versus Observation in Patients With an Ulcerated Primary Cutaneous Melanoma With T(2-4)bN0M0: a Randomized Phase III Trial of the EORTC Melanoma Group. (English)
0 references
October 2012
0 references
April 2019
0 references
1,200
0 references
18 year
0 references
70 year
0 references